Vor Biopharma VOR Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | -$116.91M+0.8% | -$117.86M-28.0% | -$92.09M-33.7% | ||
| $2.95M-18.2% | $3.61M+2.2% | $3.53M+38.0% | $2.56M+81.9% | ||
| $18.91M+92.1% | $9.85M-26.3% | $13.36M+24.9% | $10.7M+148% | ||
| -$142.71M-43.2% | -$99.66M+0.6% | -$100.29M-17.8% | -$85.14M-23.1% | ||
| $941K+311% | $229K-78.6% | $1.07M-87.4% | $8.46M+117% | ||
| -$48.8M— | —— | $71.01M+175% | -$94.09M-2.7% | ||
| $503.81M+843% | $53.42M+1,718% | $2.94M-97.5% | $117.14M-49.8% | ||
| —— | —— | —— | -$62.1M— | ||
| -$143.65M-43.8% | -$99.89M+1.5% | -$101.36M-8.3% | -$93.61M-28.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vor Biopharma generate?
- Vor Biopharma (VOR) generated -$149.9M in operating cash flow over the trailing twelve months.
- What is Vor Biopharma's free cash flow?
- After $758.0K of capital expenditures, Vor Biopharma's free cash flow was -$150.7M over the trailing twelve months, down 49.7% year over year.
- Where does Vor Biopharma's cash flow data come from?
- Every line is extracted from Vor Biopharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.